<DOC>
	<DOCNO>NCT02321345</DOCNO>
	<brief_summary>This feasibility study pre-transplant involvement palliative care provider set HCT . Although primarily feasibility pilot , investigator explore patient affect palliative care meeting well test data collection mechanism would use future randomized clinical trial . The investigator hypothesis patient amenable pre-transplant involvement palliative care team might welcome chance discus palliative care issue separate primary team . Palliative care provider also special train experience conduct interaction expertise supportive care practice . They available patient 's condition become life- threatening . This study therefore design primarily evaluate level comfort / distress patient palliative care consultation follow-up integrated care .</brief_summary>
	<brief_title>Pre-Transplant Evaluation Supportive Care Team Patients Undergoing HCT Hematological Malignancies</brief_title>
	<detailed_description>After patient provide write informed consent , give survey collect baseline data . Because input may solicit caregiver , consent also obtain caregiver . Participation optional caregiver caregiver require participant study . If caregiver consent participate study , his/her input meeting document research record . `` Caregiver '' may vary patient patient , purpose study would individual listens interview responds question related patient 's psychosocial history , goal value . This information gather caregiver support detail consult stand alone . The caregiver complete evaluation interview reach study coordinator interview cause distress.The first consultation schedule palliative care provider , take place standard care meet social worker palliative care clinician read social work note review information . Within one seven day meet palliative care , patient ask complete 15 minute interview provide feedback meeting . A brief questionnaire also administer palliative care provider conduct consultation , ideally immediately meet . Patients meet least monthly palliative care provider remain transplant center . Patients complete additional self-assessments day 60+/- 7 day 90+/- 7 day transplant . These survey may complete mail patient discharge center . The medical record participant review pilot item collect data reference palliative care consultation use ACP within first 100 day HCT . Costs participant retrieve inpatient outpatient accounting system first 100 day HCT . Participants may decline participate part study discontinue participation time .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Written inform consent English primary language Planned allogeneic stem cell transplantation At least 18 year age Major psychiatric diagnosis impairs cognitive function control time approach , judge patient 's medical team . First transplant plan tandem procedure ( second transplant eligible )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Allogeneic Stem Cell Transplant</keyword>
	<keyword>Hematological Malignancies</keyword>
	<keyword>Palliative Care</keyword>
	<keyword>Supportive care</keyword>
</DOC>